Active Ingredient History
Fecal microbiota transplant (FMT), also known as a stool transplant, is the process of transferring fecal bacteria and other microbes from a healthy individual into another individual. FMT is an effective treatment for Clostridioides difficile infection (CDI). For recurrent CDI, FMT is more effective than vancomycin alone, and may improve the outcome after the first index infection. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Clostridioides difficile (approved 2022)
Alcoholism (Phase 1)
Alopecia (Phase 2)
Alopecia Areata (Phase 2)
Alzheimer Disease (Phase 1)
Anorexia Nervosa (Early Phase 1)
Arthritis, Gouty (Phase 2)
Arthritis, Psoriatic (Phase 2)
Arthritis, Reactive (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Atherosclerosis (Phase 1)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 1)
Autoimmune Diseases (Phase 2)
Bacteria (Phase 2/Phase 3)
Bacterial Infections (Phase 2/Phase 3)
Bipolar Disorder (Phase 2/Phase 3)
Bone Marrow Transplantation (Early Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Cholangitis, Sclerosing (Phase 1/Phase 2)
Clostridioides difficile (Phase 3)
Clostridium Infections (Phase 3)
Colitis (Early Phase 1)
Colitis, Ulcerative (Phase 4)
Colonic Neoplasms (Phase 2)
Colonoscopy (Phase 3)
Colorectal Neoplasms (Early Phase 1)
Constipation (Phase 3)
COVID-19 (Phase 3)
Crohn Disease (Phase 3)
Depression (Phase 2/Phase 3)
Depressive Disorder, Major (Phase 2)
Depressive Disorder, Treatment-Resistant (Phase 2/Phase 3)
Dermatitis, Atopic (Early Phase 1)
Diabetes Insipidus (Phase 2)
Diabetes Mellitus (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Early Phase 1)
Diarrhea (Phase 2)
Drug Resistance, Bacterial (Phase 2/Phase 3)
Dysbiosis (Phase 1/Phase 2)
Enterobacteriaceae Infections (Phase 3)
Enterocolitis (Phase 2)
Enterocolitis, Pseudomembranous (Phase 2)
Epilepsy (Phase 2/Phase 3)
Fatigue Syndrome, Chronic (Phase 2)
Fecal Incontinence (Phase 1/Phase 2)
Fecal Microbiota Transplantation (Phase 3)
Feces (Phase 4)
Fibrosis (Phase 1/Phase 2)
Gastrointestinal Diseases (Phase 2)
Gastrointestinal Microbiome (Phase 4)
Gastrointestinal Motility (Phase 1)
Glomerulonephritis, IGA (Phase 2)
Graft vs Host Disease (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hepatic Encephalopathy (Phase 2)
Hepatitis, Alcoholic (Phase 3)
Hidradenitis Suppurativa (Phase 2)
HIV (Phase 1)
HIV Infections (Phase 1/Phase 2)
Hodgkin Disease (Phase 2)
Hypertension (Phase 1/Phase 2)
Infections (Phase 2/Phase 3)
Inflammation (Phase 1/Phase 2)
Inflammatory Bowel Diseases (Phase 2/Phase 3)
Insulin Resistance (Phase 2)
Intellectual Disability (Phase 2)
Intensive Care Units (Phase 2)
Intestinal Neoplasms (Phase 2)
Irritable Bowel Syndrome (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liver Cirrhosis (Phase 3)
Lymphoma (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Malnutrition (Phase 1/Phase 2)
Melanoma (Phase 2)
Metabolic Syndrome (Phase 2)
Microbiota (Phase 2/Phase 3)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 1)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasms (Early Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 4)
Obesity (Phase 2)
Obesity, Metabolically Benign (Phase 1)
Obesity, Morbid (Phase 2)
Pancreatic Neoplasms (Early Phase 1)
Parkinson Disease (Phase 1/Phase 2)
Peanut Hypersensitivity (Phase 1)
Peritonitis (Phase 4)
Pouchitis (Phase 3)
Prediabetic State (Phase 2)
Proctocolectomy, Restorative (Phase 2)
Prostatic Neoplasms (Phase 2)
Psoriasis (Phase 2)
Pulmonary Arterial Hypertension (Phase 1)
Sarcoidosis, Pulmonary (Phase 2)
Severe Acute Malnutrition (Phase 1/Phase 2)
Sjogren's Syndrome (Phase 1)
Small Cell Lung Carcinoma (Phase 2)
Spondylitis, Ankylosing (Phase 2)
Sprains and Strains (Phase 2)
Tourette Syndrome (Phase 1/Phase 2)
Urinary Tract Infections (Early Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
